Pinealon specifications and research profile
Specifications summary
| Designation | Synthetic EDR tripeptide |
|---|---|
| Also known as | Pinealon; EDR peptide |
| Sequence / composition | Glu-Asp-Arg |
| Strength | 10mg × 10 vials |
| Presentation | 10-vial case |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
Pinealon is the short regulatory tripeptide Glu-Asp-Arg (EDR). It is used as a defined sequence reference in neuronal-cell and peptide-dependent gene-expression research.
Published literature discusses transcriptional, protein-synthesis and neuronal-culture observations, with much of the evidence originating from preclinical systems. Claims should remain limited to the tested models.
Applications in research
- EDR sequence and fragment comparisons
- Neuronal-cell gene-expression panels
- MAPK/ERK and apoptosis-marker research models
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Research references
Pinealon research record
Clear product, batch, storage, dispatch and document information for this 10-vial case.
Research context
The Glu-Asp-Arg tripeptide is studied in neuronal-cell, gene-expression and protein-synthesis models, with evidence primarily from preclinical systems.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.